Allison Sayre, MSN, WHNP
What do gut bacteria have to do with ovarian hormones, insulin sensitivity, and PCOS? Potentially more than we once thought. The gut microbiome appears to be connected with several biological pathways involved in polycystic ovary syndrome (PCOS), now known as polyendocrine metabolic ovarian syndrome (PMOS). These include insulin signaling, androgen metabolism, inflammation, and communication between the gut and brain. [1][2]
PMOS is a complex endocrine condition characterized by features that can include elevated androgen levels, ovulatory dysfunction, and polycystic ovarian changes. It can also be accompanied by insulin resistance, impaired glucose metabolism, dyslipidemia, and abdominal obesity. [1][2] The gut microbiome may be another piece of this larger metabolic and reproductive picture.
That does not mean an altered microbiome causes PMOS. The direction and significance of these relationships are still being worked out. But the science raises an intriguing possibility. The microorganisms living in the gut may be participating in biological conversations happening far beyond the gastrointestinal tract.
First, What Is the Gut Microbiome?
The gut microbiome refers to the enormous community of microorganisms that live within the gastrointestinal tract. These organisms coexist with us throughout life and interact with systems involved in metabolism, immune function, and endocrine signaling. [1] Interestingly, the composition of this microbial community appears to differ in people with PMOS.
Differences have been observed in both microbial diversity and the abundance of certain bacteria compared with people without PMOS. The microbiome may also differ between people with PMOS who have insulin resistance and those who do not. [1]
That last point is particularly interesting because insulin resistance is one of the most common metabolic features associated with PMOS. An estimated 50% to 70% of people with PMOS experience some degree of insulin resistance, with an even greater prevalence among those with obesity. [1] And this is where the microbiome conversation gets even more interesting.
The Gut-Insulin Connection
Insulin resistance occurs when cells become less responsive to insulin, disrupting normal glucose regulation and prompting the body to compensate. In PMOS, insulin resistance can interact with other metabolic and hormonal abnormalities, including elevated androgen levels. [1][2] The gut microbiome may intersect with this process through several pathways.
One involves short-chain fatty acids(SCFAs). These compounds are produced by intestinal bacteria and have roles in metabolic signaling. Changes in the gut microbiome can alter SCFA production, creating another potential connection between the intestinal environment and insulin sensitivity. [1]
There is also an interesting relationship among gut bacteria, bile acids, and immune signaling. Changes involving Bacteroides have been associated with alterations in bile acid metabolism and IL-22, an immune signaling molecule that may be connected with insulin sensitivity and ovarian function. [1]
Translation: The metabolic activity of the gut microbiome does not necessarily stay in the gut.
PMOS, the Gut Barrier, and Inflammation
PMOS is associated with chronic low-grade inflammation, and the intestinal barrier may be another piece of the puzzle. The gut lining normally creates a selective barrier between the intestinal environment and the rest of the body. When the integrity of that barrier is disrupted, bacterial components such as lipopolysaccharide (LPS), may more easily enter circulation. [1][2] LPS is a component of the cell wall of certain Gram-negative bacteria. Once it enters circulation, it can interact with immune signaling pathways and promote the production of inflammatory mediators. [1]
So, why does this matter for PMOS? Inflammatory markers including C-reactive protein, TNF-alpha (tumor necrosis factor-alpha), and certain interleukins (IL-1 and IL-6) can be elevated in people with PMOS. Alterations in the gut microbiome and intestinal barrier function may be connected with this inflammatory environment. [1] And the relationship can become complicated quickly. Insulin resistance itself can contribute to chronic inflammation, creating the possibility of feedback loops among metabolic function, immune activity, and the intestinal environment. [1]
Instead of thinking about each pathway by itself, it may be more useful to picture them as one big network.
Can Gut Bacteria Influence Androgens?
Here is where things get especially interesting. Hormones may influence the microbiome, and the microbiome may influence hormones. Androgen exposure has been associated with changes in gut microbial diversity and composition in animal models. Other animal experiments indicate that intestinal microorganisms may influence testosterone levels and metabolic function. [1][2]
These findings raise a fascinating chicken-or-the-egg question. Does an altered microbiome contribute to hormonal changes? Do elevated androgens reshape the microbiome? Or could the relationship move in both directions? We do not have a simple answer yet.
Much of the mechanistic evidence connecting gut bacteria and androgen activity comes from animal models, so these findings cannot automatically be applied to humans. They do, however, offer potential clues about how reproductive, metabolic, and inflammatory changes may intersect in PMOS. [1]
Don't Forget the Gut-Brain Axis
The gut and brain are in constant communication. This bidirectional network, known as the gut-brain axis, involves the central nervous system, enteric nervous system, immune signaling, the hypothalamic-pituitary-adrenal axis, microbial metabolites, hormones, and neurotransmitters. [1][2]
Gut bacteria can produce metabolites such as SCFAs that interact with intestinal endocrine cells and influence signaling molecules including GLP-1, ghrelin, and peptide YY. These molecules participate in processes related to appetite, metabolism, insulin secretion, and reproductive signaling. [1]
Ghrelin, for example, can interact with hypothalamic and pituitary pathways involved in luteinizing hormone (LH) secretion. LH helps regulate ovulation and ovarian hormone production, and altered LH signaling is commonly seen in PMOS. [1] This creates another potential biological bridge between what is happening in the gastrointestinal tract and what is happening within the reproductive system. [1]
There is still plenty to learn about how meaningful these connections are in people with PMOS, but the concept reinforces something important and that is that the ovaries do not operate in isolation.
PMOS Is a Whole-Body Conversation
The microbiome adds another dimension to how we think about PMOS. Insulin signaling, androgen activity, immune function, intestinal barrier integrity, microbial metabolites, and gut-brain communication may all intersect. The gut microbiome could be one participant within this larger physiological network. [1] That does not make the gut the missing answer to PMOS. There is still a lot we do not know about which microbiome changes are meaningful, whether they contribute to PMOS or occur because of it, and how these relationships differ from one person to another.
What this does offer is a broader way to think about a condition often reduced to periods, ovaries, and hormones. PMOS can involve reproductive and metabolic physiology at the same time. The gut microbiome gives us another window into how closely those systems may communicate.
For people with PMOS, the takeaway is less about chasing a perfect microbiome and more about recognizing how interconnected these systems are. Practitioners can help evaluate PMOS within this broader context and determine which evidence-based strategies are appropriate based on an individual's needs. The gut may not hold the entire PMOS story, but it definitely deserves to be part of the conversation.
Disclaimer:
The information provided is for educational purposes only. Consult your physician or healthcare practitioner if you have specific questions before instituting any changes in your daily lifestyle including changes in diet, exercise, and supplement use.
Allison Sayre, MSN, WHNP is a board-certified women’s health nurse practitioner with advanced expertise in hormonal health, integrative gynecology, and patient-centered care across the lifespan. She holds a Master of Science in Nursing and has served as both a clinical provider and educator in functional and conventional women’s health settings. At ARG, Allison contributes to medical education, clinical protocol development, and strategic content that supports the evolving needs of women's healthcare practitioners.
